Patent intelligence · US
US 11802157
Methods and compositions for modulating CAR-T activity
Methods and compositions for modulating CAR-T activity
Patent details — US 11802157
- Jurisdiction
- US
- Status
- granted
- Grant date
- Oct 31, 2023
- Expiration
- Oct 26, 2043
- Applicant
- Sana Biotechnology, Inc.
- Claims
- 27
- CPC classes
- A61K, A61K2039/505, A61K2039/804, A61K2239/31
Quick answer
US 11802157 (Methods and compositions for modulating CAR-T activity) is held by Sana Biotechnology, Inc.. Status: granted. Granted Oct 31, 2023. Expires Oct 26, 2043 (17 years remaining) — relevant for patent-cliff and LOE planning.
Key facts
- Applicant
- Sana Biotechnology, Inc.
- Grant date
- Expiration
- Claims
- 27
- CPC classes
- A61K, A61K2039/505, A61K2039/804, A61K2239/31, A61K2239/38, A61K2239/48
More from Sana Biotechnology, Inc.
Related pharmaceutical patents in our USPTO index.
-
US 12427199
Self-assembled diblock copolymers composed of pegmema and drug bearing polymeric segments
granted -
US 12409213
Live attenuated oral vaccine against shigellosis and typhoid fever
granted -
US 12246059
Stable hybrid FC fusion G-CSF formulation
granted -
US 12171822
Infectious plasmodium sporozoites grown in vitro
granted -
US 12156870
Antibody drug conjugates comprising sting agonists
granted -
US 12129288
Polynucleotides heterodimers of soluble interferon receptors and uses thereof
granted -
US 12077543
P2X3 and/or P2X2/3 compounds and methods
granted -
US 11987628
Methods and compositions for modulating CAR-T activity
granted
Frequently asked questions
What is US patent 11802157?
US 11802157 (Methods and compositions for modulating CAR-T activity) is held by Sana Biotechnology, Inc.. Status: granted. Granted Oct 31, 2023. Expires Oct 26, 2043 (17 years remaining) — relevant for patent-cliff and LOE planning.
Who owns US 11802157?
Sana Biotechnology, Inc. is listed as the applicant in USPTO PatentsView records indexed by NovaPharmaNews. We track 136 pharmaceutical patents for this assignee.
When does US 11802157 expire?
Our index shows an expiration date of Oct 26, 2043 (17 years from today). Confirm material dates against USPTO, FDA Orange Book, or qualified counsel before contractual decisions.